The University of Glasgow, with assistance from colleagues at Lancaster University, the University of Oxford and the University of Warwick, have published a series of guided self-help booklets developed to support people with mild to moderate learning/intellectual disabilities during the COVID-19 outbreak.
Chronic Headache Education and Self-management Study (CHESS) is a multi-centre, randomised controlled trial evaluating an education and self-management support programme for people living with chronic headaches (headache ≥ 15 days/month for ≥ 3 months).
ALL HEART (Allopurinol and cardiovascular outcomes in patients with ischaemic heart disease) is a major multi-centre trial of allopurinol up to 600mg daily versus no treatment added to usual therapy in patients aged 60 years and over with ischaemic heart disease. The aim is to establish whether allopurinol improves cardiovascular outcomes in this population.
Linear and non-linear brain changes over the transition to psychosis
We are looking for volunteers (16-35 years old) to take part in an imaging study about brain changes associated with mental health at the University of Birmingham.
Continued thanks to those practices recruiting to the CANDID study which is set to continue until the 30th September 2016. Congratulations to our top ten recruiting practices to date this year.
FAST (Febuxostat versus Allopurinol Streamlined Trial) is a major multicentre clinical trial evaluating long term cardiovascular safety of febuxostat in comparison with allopurinol in patients with chronic symptomatic hyperuricaemia (gout). This is a very simple study, with a very low workload for participating practices.
(Treatment In Morning vs Evening) is looking at patients taking once a day blood pressure medication, aiming to establish whether night time dosing is better (or worse) than morning time treatment in preventing heart attacks, strokes, and deaths related to diseases of the heart and circulation.